ArticleAnnals of translational medicine2023

Efficacy and safety of tucidinostat in patients with advanced hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer: real-world insights.

Jiaojiao Suo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.